Estimated annual CRC deaths attributable to per-patient average delay in CRC diagnostic pathway of 2/4/6 months (assuming no prioritisation based on FIT)
| Age band | CRC stage | Average per-patient delay in diagnosis Aggregate attributable deaths per year in England (2WW CRC cases) | ||
| 2 months | 4 months | 6 months | ||
| 30–39 years | Stage 1 | 0.1 | 0.2 | 0.3 |
| Stage 2 | 1.3 | 3.1 | 5.3 | |
| Stage 3 | 2.8 | 6.1 | 9.8 | |
| 40–49 years | Stage 1 | 0.9 | 2.1 | 3.8 |
| Stage 2 | 5.2 | 12 | 20.5 | |
| Stage 3 | 11.1 | 24.1 | 38.3 | |
| 50–59 years | Stage 1 | 3.8 | 9.3 | 16.9 |
| Stage 2 | 20.1 | 46.6 | 80.7 | |
| Stage 3 | 44.5 | 97.4 | 155.9 | |
| 60–69 years | Stage 1 | 6.4 | 16 | 29.6 |
| Stage 2 | 36.3 | 84.7 | 146.2 | |
| Stage 3 | 74.9 | 163.7 | 260.7 | |
| 70–79 years | Stage 1 | 15.3 | 38.5 | 70.9 |
| Stage 2 | 67.5 | 156.6 | 266.3 | |
| Stage 3 | 133 | 279.2 | 421.6 | |
| 80+ years | Stage 1 | 36.6 | 84.4 | 140.8 |
| Stage 2 | 73.5 | 166.8 | 273.7 | |
| Stage 3 | 119.9 | 228.5 | 308.9 | |
Based on 10-year net survival and disruption spanning 1 year in which on average 11 226 patients with CRC would be diagnosed with CRC in England via the 2WW pathway. Deeper shading indicates greater impact in attributable deaths.